Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes: Scientific Impact Paper No. 58

BJOG. 2019 Feb;126(3):e107-e113. doi: 10.1111/1471-0528.15468. Epub 2018 Nov 6.
No abstract available

MeSH terms

  • ADAM12 Protein / blood
  • Activins / blood
  • Adrenomedullin / blood
  • Biomarkers / blood
  • CA-125 Antigen / blood
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Creatine Kinase / blood
  • Disintegrins / blood
  • Fallopian Tube Diseases / blood
  • Female
  • Glycodelin / blood
  • Humans
  • Leukemia Inhibitory Factor / blood
  • Membrane Proteins / blood
  • Placental Lactogen / blood
  • Pregnancy
  • Pregnancy Complications / blood
  • Pregnancy Complications / diagnosis
  • Pregnancy Trimester, First / blood*
  • Pregnancy, Ectopic / blood*
  • Pregnancy, Ectopic / diagnosis
  • Pregnancy-Associated Plasma Protein-A / metabolism
  • Pregnancy-Specific beta 1-Glycoproteins / metabolism
  • Progesterone / blood*
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor Receptor-1 / blood

Substances

  • Biomarkers
  • CA-125 Antigen
  • Chorionic Gonadotropin, beta Subunit, Human
  • Disintegrins
  • Glycodelin
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • MUC16 protein, human
  • Membrane Proteins
  • PAEP protein, human
  • PIGF protein, human
  • Pregnancy-Specific beta 1-Glycoproteins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • activin A
  • Activins
  • Adrenomedullin
  • Progesterone
  • Placental Lactogen
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Creatine Kinase
  • ADAM12 Protein
  • ADAM12 protein, human
  • Pregnancy-Associated Plasma Protein-A
  • PAPPA protein, human